Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $48.70 Analyst target: $59.12 Upside: 21.40%
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
See the full interactive analysis & chart →Informational only — not investment advice.